BIOTEST
Live / Applied — Fourth extension granted (statement of use) (as of 04 Sept 2025)
What this means for you
Not registered yet, but its 24 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 76720853
- Mark type
- Stylized text
- Filed
- 24 Jun 2022
- Published for opposition
- 29 Aug 2023
- Attorney of record
- John W. McGlynn
Goods and services
- Class 001 — Chemicals: Biological preparations for use in industry and science, namely, proteins and protein preparations made from human blood, blood plasma or blood serum, in particular human albumin, coagulation factors and immunoglobulins; recombinant proteins for industrial and scientific use; plasma fractions in the nature of biological preparations for industrial and scientific use; excipients for the stabilization of medicines, in particular human albumin for industrial and scientific purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating infectious diseases and diseases of the immune system, namely, proteins and protein preparations made from human blood, blood plasma or blood serum; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, human albumin, coagulation factors and coagulation inhibitors, in particular factor VIII, factor IX, factor X, fibrinogen; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, recombinant proteins, in particular coagulation factors and monoclonal antibodies; pharmaceutical preparations for haematology, immunology, neurology, intensive medicine, transplantation medicine, oncology for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and disorders, cancer and infections; pharmaceutical preparations for preventing and treating viral diseases, for treating diseases of the immune system, for treating autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying and toxin-neutralizing medicines
Owner
- Biotest AG, Dreieich, DE
- Biotest AG, DE
Prosecution history
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 4 GRANTED
- 04 Sept 2025 — SOU EXTENSION 4 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2025 — SOU EXTENSION 3 GRANTED
- 04 Apr 2025 — SOU EXTENSION 3 FILED
- 04 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2024 — SOU EXTENSION 2 GRANTED
- 07 Oct 2024 — SOU EXTENSION 2 FILED
- 07 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2024 — SOU EXTENSION 1 GRANTED
- 24 Apr 2024 — SOU EXTENSION 1 FILED